- Home
- EBS vs LASR Comparison
EBS vs LASR Comparison
Compare EBS & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- LASR
- Stock Information
- Founded
- EBS 1998
- LASR 2000
- Country
- EBS United States
- LASR United States
- Employees
- EBS N/A
- LASR N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- LASR Semiconductors
- Sector
- EBS Health Care
- LASR Technology
- Exchange
- EBS Nasdaq
- LASR Nasdaq
- Market Cap
- EBS 393.9M
- LASR N/A
- IPO Year
- EBS 2006
- LASR 2018
- Fundamental
- Price
- EBS $6.38
- LASR $8.61
- Analyst Decision
- EBS Strong Buy
- LASR Strong Buy
- Analyst Count
- EBS 3
- LASR 4
- Target Price
- EBS $14.33
- LASR $15.13
- AVG Volume (30 Days)
- EBS 1.1M
- LASR 268.3K
- Earning Date
- EBS 05-07-2025
- LASR 05-08-2025
- Dividend Yield
- EBS N/A
- LASR N/A
- EPS Growth
- EBS N/A
- LASR N/A
- EPS
- EBS N/A
- LASR N/A
- Revenue
- EBS $965,400,000.00
- LASR $198,548,000.00
- Revenue This Year
- EBS N/A
- LASR $8.26
- Revenue Next Year
- EBS $19.88
- LASR $10.40
- P/E Ratio
- EBS N/A
- LASR N/A
- Revenue Growth
- EBS N/A
- LASR N/A
- 52 Week Low
- EBS $4.02
- LASR $6.20
- 52 Week High
- EBS $15.10
- LASR $14.73
- Technical
- Relative Strength Index (RSI)
- EBS 65.88
- LASR 60.32
- Support Level
- EBS $4.71
- LASR $7.88
- Resistance Level
- EBS $5.70
- LASR $8.60
- Average True Range (ATR)
- EBS 0.38
- LASR 0.33
- MACD
- EBS 0.13
- LASR 0.16
- Stochastic Oscillator
- EBS 85.77
- LASR 97.38
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.